Experienced in Teratoma of the Mediastinum

Dr. Casey M. Cosgrove

Gynecologic Oncology | Oncology
Osu Gyn And Ob Consultants, LLC
3651 Ridge Mill Dr, 
Hilliard, OH 
Accepting New Patients
Offers Telehealth
Experienced in Teratoma of the Mediastinum
Osu Gyn And Ob Consultants, LLC
3651 Ridge Mill Dr, 
Hilliard, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Casey Cosgrove is a Gynecologic Oncologist and an Oncologist in Hilliard, Ohio. Dr. Cosgrove is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Desmoplastic Small Round Cell Tumor, Hysterectomy, and Vulvectomy. Dr. Cosgrove is currently accepting new patients.

His clinical research consists of co-authoring 80 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Teratoma of the Mediastinum.

Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in OH
Hospital Affiliations
Ohio State University State Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

OSU GYN AND OB CONSULTANTS, LLC
3651 Ridge Mill Dr, Hilliard, OH 43026

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Biological, Drug
Study Drugs: Oregovomab, Paclitaxel, Carboplatin
Study Phase: Phase 3
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 2
View 2 Less Clinical Trials

80 Total Publications

A prospective, nonrandomized clinical investigation of the da Vinci surgical system model IS5000.
A prospective, nonrandomized clinical investigation of the da Vinci surgical system model IS5000.
Journal: Journal of robotic surgery
Published: August 26, 2025
Similar Doctors
Advanced in Teratoma of the Mediastinum
Dr. J P. Monk
Oncology
Advanced in Teratoma of the Mediastinum
Dr. J P. Monk
Oncology

Osu Internal Medicine LLC

452 W 10th Ave, 
Columbus, OH 
 (5.6 miles away)
614-293-3737
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

J Monk is an Oncologist in Columbus, Ohio. Dr. Monk is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Monk is currently accepting new patients.

Advanced in Teratoma of the Mediastinum
Dr. Shakir Sarwar
Hematology Oncology | Hematology | Oncology
Advanced in Teratoma of the Mediastinum
Dr. Shakir Sarwar
Hematology Oncology | Hematology | Oncology

Ohiohealth Corporation

1030 Refugee Rd, Suite 300, 
Pickerington, OH 
 (19.4 miles away)
614-566-2286
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Shakir Sarwar is a Hematologist Oncology specialist and a Hematologist in Pickerington, Ohio. Dr. Sarwar is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Sarwar is currently accepting new patients.

Experienced in Teratoma of the Mediastinum
Dr. Peng Wang
Oncology
Experienced in Teratoma of the Mediastinum
Dr. Peng Wang
Oncology

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (4.8 miles away)
614-366-5001
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Peng Wang is an Oncologist in Dublin, Ohio. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Penile Cancer, Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, and Endoscopy. Dr. Wang is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cosgrove's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile